Cargando…
YY1 suppresses FEN1 over-expression and drug resistance in breast cancer
BACKGROUND: Drug resistance is a major challenge in cancer therapeutics. Abundant evidence indicates that DNA repair systems are enhanced after repetitive chemotherapeutic treatments, rendering cancers cells drug-resistant. Flap endonuclease 1 (FEN1) plays critical roles in DNA replication and repai...
Autores principales: | Wang, Jianwei, Zhou, Lina, Li, Zhi, Zhang, Ting, Liu, Wenpeng, Liu, Zheng, Yuan, Yate-Ching, Su, Fan, Xu, Lu, Wang, Yan, Zhou, Xiaotong, Xu, Hong, Hua, Yuejin, Wang, Ying-Jie, Zheng, Li, Teng, Yue-E, Shen, Binghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348373/ https://www.ncbi.nlm.nih.gov/pubmed/25885449 http://dx.doi.org/10.1186/s12885-015-1043-1 |
Ejemplares similares
-
Chemical-induced cancer incidence and underlying mechanisms in Fen1 mutant mice
por: Xu, Hong, et al.
Publicado: (2010) -
The FEN1 E359K germline mutation disrupts the FEN1-WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancers
por: Chung, Lin, et al.
Publicado: (2014) -
Methylation of FEN1 suppresses nearby phosphorylation and facilitates PCNA binding
por: Guo, Zhigang, et al.
Publicado: (2010) -
SUMO-1 modification of FEN1 facilitates its interaction with Rad9–Rad1–Hus1 to counteract DNA replication stress
por: Xu, Xiaoli, et al.
Publicado: (2018) -
Functional regulation of FEN1 nuclease and its link to cancer
por: Zheng, Li, et al.
Publicado: (2011)